Artificial intelligence (AI) may not be building better versions of itself yet, but Anthropic says the world is moving closer to that possibility than many people realize. In a new research paper ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

Prime-Indexed Recursive Tensor Mathematics (PIRTM) is a foundational mathematical framework within Multiplicity Theory that models dynamic systems using tensors indexed by prime numbers. By assigning ...

It’s about to cost Prime Video users in the U.S. more if they want to stream TV shows and movies without ads. On April 10, 2026, Prime Video’s ad-free subscription will become Prime Video Ultra in the ...

Amazon is hiking the price of its ad-free Prime Video subscription tier. The service will cost $4.99 a month in the U.S., up from $2.99 per month, starting April 10. Amazon introduced ads to its ...

These properties make PIRTM suitable as the safety-critical inner loop for AI inference engines, certified control systems, and any computation that must be auditable after the fact. Classical ...

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...